To include your compound in the COVID-19 Resource Center, submit it here.
Civitas Therapeutics Inc. (Chelsea, Mass.) and EyeGate Pharmaceuticals Inc. (Waltham, Mass.) each set terms for their proposed IPOs
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury